Cytomegalovirus Colitis Following Azacitidine Therapy. Issue 3 (2011)

• Record Type: Journal Article
• Authors: Khan, Rajal; Rudkin, Pam; Grewal, Kuljit; Leonard, Jennifer; Hamodat, Mowafak; Hutchinson, Jim; Daley, Peter
• Is Part Of: Canadian journal of infectious diseases & medical microbiology =. Volume 22:Issue 3(2011)
• Page Start: e21
• Page End: e23
• Publication Date: 2011
• Subjects: Azacitidine -- CMV -- Colitis; Communicable diseases -- Periodicals; Infection -- Periodicals; Communicable diseases; Infection; Communicable Diseases; Communicable Disease Control; Electronic journals; Periodicals; Fulltext; Internet Resources; Periodicals; 616.9
• DOI: 10.1155/2011/616725
• Languages: English
• ISSNs: 1712-9532

Abstract

Abstract : The present report describes the first recognized case of cytomegalovirus (CMV) colitis following azacitidine therapy. A 66-year-old woman with myelodysplastic syndrome developed CMV colitis, which responded to treatment with ganciclovir. Currently, patients receiving azacitidine do not undergo CMV testing, or receive prophylaxis or CMV-free blood products; however, this policy needs to be revised.